In 2023, the contraceptive prevalence rate in the US was approximately 74.7% among women aged 15-49. The forecast data suggests a stable increase in usage from 74.9% in 2024 to 75.2% in 2028, exhibiting a modest year-on-year growth of about 0.13% on average. The compound annual growth rate (CAGR) over the forecast period remains at approximately 0.07%, indicating a steady maturation in contraceptive adoption. This reflects a largely saturated market with minimal fluctuations.
Future trends to watch for:
- Technological advancements in contraceptives.
- Policy changes affecting reproductive health access.
- Shifts in demographic and social attitudes towards family planning.
